We are in the business of designing innovative digital strategies that drive commercial impact for our clients. That requires zero-conflict objectivity. No favorite technologies or platforms. No go-to vendors. No off-the-shelf solutions.
We answer only to our clients. With no ties to execution or spend we are able to provide tailor-made strategic recommendations, free of secondary motivations.
Committed to people, patients and outcomes
We are solely focused on developing and implementing clear, specific and practical digital innovation, built on defensible rationale that works in the marketplace. We zero in on driving topline impact, optimizing cost efficiencies, minimizing risk and, ultimately, solving for the unmet needs of the brand, healthcare providers and patients.
We help our clients achieve business goals and improve health outcomes.
A track record of commercial impact
With a 20+ year track record of successful life sciences digital innovation, we leverage our market-proven approaches and methodologies to drive impact. We identify strategic opportunities and validate commercial viability, weighing risk and impact. We prioritize solutions that align with brand, healthcare provider and patient goals.
Our experience is built on our expertise, client relationships and commitment to doing the right thing. That is how we deliver digital innovation.
Driving better results
We are life sciences digital innovation thought leaders. From that market position, we help our clients solve critical commercial challenges, enabling them to act with confidence, increase business results and improve health outcomes.
We are a cohesive, seasoned team, dedicated to leveraging meaningful, measurable digital innovation across the entire life sciences landscape.
What they're saying
I’ve worked with the Evolution Road team for more than 15 years. I have full trust and confidence in their work and counsel as they always prioritize what’s best for our business and our patients above anything else. Their strategic, patient-centric, analytical, objective and enterprise-wide approach to solving business problems enables me to fully rely on them as key business partners.
Christine Sakdalan, Head of Franchise Strategy & Solutions, Janssen
What is Connected TV, and what does it mean for Pharma Marketers?
Accelerated by the pandemic, TV consumption is changing and continues to decline due to fragmentation in the space. Traditional TV consumption on a single TV is quickly transitioning to increased on-demand streaming across multiple devices.Changing technology, paired with evolved TV watching, requires pharma marketers to modify their traditional approach to TV investment. Pharma has invested heavily in TV due to its reach capabilities, but now with Connected TV advertising (CTV), marketers can be even more savvy by reaching highly qualified audiences on TV more efficiently to drive brand impact.
April 25, 2022
Evolution Road’s 22nd Holiday Dinner | Being Thankful
In December, we held our 22nd Holiday Dinner, and had a blast! We held a Rock ‘n Roll Happy Hour to celebrate, enjoyed classic rock trivia, name that tune and even co-created a song with everyone helping with the tune and the lyrics (of course we had professional help here). Unfortunately, we weren’t able to be together in person, but fortunately, we were able to have a lot of fun virtually and spend time with each other, and all our families, together. It warmed my heart, and I am so thankful we had the chance to celebrate together.
January 12, 2022
Kate Miller Named Chief Strategy Officer at Evolution Road
Kate Miller has been promoted to the position of Chief Strategy Officer from the position of Digital Innovation/Commercialization Practice Lead. She has been with the firm for nearly 14 years and was previously the Vice President of Strategy. Kate will be responsible for ER’s market vision, positioning and branding, thought leadership and intellectual property.
August 30, 2021
Announcing Decoding Digital Health for Life Sciences
The ER team is pleased to invite you to a new industry event called Decoding Digital Health for Life Sciences, running June 15-16, 2021. This event will help Life Science brand and commercial teams better understand the digital health opportunity and how to leverage digital health to improve patient outcomes and drive commercial success. Decoding Digital Health was co-created by Evolution Road and ER's own Paul Ivans & Todd Kolm are the conference co-chairs.
April 20, 2021
Using big data to boost engagement, conversion and revenue
One of the country’s largest pharmaceutical companies and a top health information technology company had always wanted to work together, yet the right opportunity never presented itself. Taking an independent, objective view, we found one driven by data.
With the objective of driving awareness and education across an entire portfolio and, ultimately, incremental treatment rates and improved patient outcomes, we layered multiple data sources to inform a multi-pronged digital communications strategy that reached three million patients and drove $40 million in incremental revenue.
March 23, 2021
Reimagining patient engagement
A multinational pharmaceutical manufacturer knew there was room to improve engagement and adherence amongst its diabetes patients.
Where standard approaches fell short, we created the digital strategy, guided program development and piloted a multi-touch engagement program designed to meet patients on their terms—with deep personalization and less friction.
March 23, 2021
Eliminating care gaps through digital innovation
One of the world’s top pharmaceutical companies sought to narrow gaps in care across its entire vaccine portfolio.
Cultivating a collaborative partnership for our client with CareSpeak, an OptimizeRx company that offers an interactive health messaging platform, we crafted a comprehensive member communications strategy that sparked measurable, meaningful engagement.
March 22, 2021
Telemedicine is here to stay: How the barriers are breaking down
Historically, telemedicine has been impeded by three main barriers: applicability, lack of insurance coverage, and technology. However, with COVID and innovation as accelerators, telemedicine is breaking through.
February 3, 2021